The rapid growth of the Breast Implants Market has been driven by the growing demand for improving physical aesthetics. The global healthcare sector has been impacted by the COVID-19 pandemic, while the pandemic had a substantial impact on the medical equipment industry. There was a rapid increase in demand for personal protective equipment and ventilators, whilst on the opposite end, consumption of health devices/products including implants, injectables, stents, & equipment was observably falling.
Global Breast Implants Market size was valued at USD 2.5
billion in 2023 and is poised to grow from USD 2.74 billion in 2024 to USD 5.75
billion by 2032, growing at a CAGR of 9.7% during the forecast period
(2025-2032).
Get your free sample report: https://www.skyquestt.com/sample-request/breast-implants-market
Key Growth Factors:
- Increasing
number of cosmetic surgeries worldwide.
- Growing
acceptance of aesthetic enhancement among younger and middle-aged
populations.
- Rising
demand for breast reconstruction after mastectomy.
- Continuous
innovation in implant design and safety.
Breast Implants Market Segments Analysis
Global Breast Implants Market is segmented by Product,
Shape, Application, Texture, End-User and region.
·
Based on Product, the market is segmented into
Silicone Breast Implants and Saline Breast Implants.
·
Based on Shape, the market is segmented into
Round and Anatomical.
·
Based on Application, the market is segmented
into Reconstructive Surgery and Cosmetic Surgery.
·
Based on Texture, the market is segmented into
Smooth and Textured.
·
Based on End-User, the market is segmented into
Hospitals, Cosmetology Clinics and Ambulatory Surgical Centers.
·
Based on region, the market is segmented into
North America, Europe, Asia Pacific, Latin America and Middle East &
Africa.
Breast Implants Market Regional Insights
North America is dominating with the largest Breast Implants
Market share. The dominant position of North America can be explained by the
increasing healthcare spending in the U.S. and the demand for cosmetic surgical
procedures that in most cases are related to the improvement of a person's
esthetic appearance.
The Asia Pacific is poised for substantial growth during the
forecast period owing to increasing disposable income in countries such as
India, China, which creates a growth opportunity for medical tourism low-cost
treatments in the region.
Top Player's Company Profiles
·
Establishment Labs S.A. (Costa Rica)
·
Ideal Implant Inc. (USA)
·
GC Aesthetics plc (Ireland)
·
POLYTECH Health & Aesthetics GmbH (Germany)
·
Laboratoires Arion (France)
·
CEREPLAS (France)
·
Groupe Sebbin SAS (France)
·
HansBiomed Co. Ltd. (South Korea)
·
Silimed Indústria de Implantes Ltda. (Brazil)
·
Eurosilicone S.A.S. (France)
·
Nagor Ltd. (United Kingdom)
·
Shanghai Kangning Medical Device Co. Ltd.
(China)
·
Guangzhou Wanhe Plastic Materials Co. Ltd.
(China)
·
Technomed India Pvt. Ltd. (India)
·
PMT Corporation (USA)
·
Koken Co. Ltd. (Japan)
·
Trulife (Ireland)
·
BellaSeno GmbH (Germany)
·
CollPlant Biotechnologies Ltd. (Israel)
Recent Developments in Breast Implants Market
·
In August 2023, Collplant and Stratasys
collaborated to integrate Collplant’s rhCollagen-based Bioinks with Stratasys
P3 technology-based bioprinter. This will help in developing regenerative
breast implants.
·
In January 2023, Establishment Labs partnered
with Seishin Plastic and Aesthetic Surgery Clinic. The objective of the
partnership was to introduce Mia Femtech breast implants in the Japanese
market.
·
In October 2022, GC Aesthetics made announcement
that CE has given its approval for LUNA xt. This is a micro-textured anatomical
breast implant that became the first implant approved under the European
Medical Device Regulation.
Explore full report: https://www.skyquestt.com/report/breast-implants-market
No comments:
Post a Comment